PriceTargets.com logo

Allurion Technologies - ALUR Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $2.88
  • Forecasted Upside: 726.15%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$0.35 As of 12/20/2024 06:45 PM ET
▲ +0.0681 (24.33%)

This chart shows the closing price for ALUR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Allurion Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALUR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALUR

Analyst Price Target is $2.88
▲ +726.15% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Allurion Technologies in the last 3 months. The average price target is $2.88, with a high forecast of $5.00 and a low forecast of $2.00. The average price target represents a 726.15% upside from the last price of $0.35.

This chart shows the closing price for ALUR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Allurion Technologies.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/25/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/23/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/22/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/22/2024

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2024Chardan CapitalDowngradeBuy ➝ Neutral
10/2/2024TD CowenInitiated CoverageBuy$2.00
9/6/2024Roth CapitalUpgradeStrong-Buy
9/6/2024Roth MkmInitiated CoverageBuy$2.00
8/22/2024Chardan CapitalLower TargetBuy ➝ Buy$5.00 ➝ $2.50
5/15/2024Chardan CapitalReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
4/4/2024Chardan CapitalInitiated CoverageBuy$5.00
2/9/2024Jefferies Financial GroupInitiated CoverageBuy$5.00
(Data available from 12/22/2019 forward)

News Sentiment Rating

0.35 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/26/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/25/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/25/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/24/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/23/2024
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2024
  • 0 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/22/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/22/2024

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Allurion Technologies logo
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Read More

Today's Range

Now: $0.35
Low: $0.28
High: $0.36

50 Day Range

MA: $0.53
Low: $0.28
High: $0.77

52 Week Range

Now: $0.35
Low: $0.26
High: $4.00

Volume

663,921 shs

Average Volume

734,072 shs

Market Capitalization

$22.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Allurion Technologies?

The following Wall Street sell-side analysts have issued research reports on Allurion Technologies in the last year: Chardan Capital, Jefferies Financial Group Inc., Roth Capital, Roth Mkm, and TD Cowen.
View the latest analyst ratings for ALUR.

What is the current price target for Allurion Technologies?

0 Wall Street analysts have set twelve-month price targets for Allurion Technologies in the last year. Their average twelve-month price target is $2.88, suggesting a possible upside of 726.1%. Jefferies Financial Group Inc. has the highest price target set, predicting ALUR will reach $5.00 in the next twelve months. Roth Mkm has the lowest price target set, forecasting a price of $2.00 for Allurion Technologies in the next year.
View the latest price targets for ALUR.

What is the current consensus analyst rating for Allurion Technologies?

Allurion Technologies currently has 1 hold rating, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ALUR will outperform the market and that investors should add to their positions of Allurion Technologies.
View the latest ratings for ALUR.

What other companies compete with Allurion Technologies?

Other companies that are similar to Allurion Technologies include InspireMD, Vivani Medical, Hyperfine, Apyx Medical and Milestone Scientific. Learn More about companies similar to Allurion Technologies.

How do I contact Allurion Technologies' investor relations team?

Allurion Technologies' physical mailing address is 11 Huron Drive, Natick, MA 01760, United States. The company's listed phone number is 508-647-4000 and its investor relations email address is [email protected]. The official website for Allurion Technologies is www.allurion.com. Learn More about contacing Allurion Technologies investor relations.